PATENT CLAIM ANALYSIS

Application Number: 16206814
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "312000"]

Abstract:
The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.

Claim (Index 15):
The solid solution pharmaceutical composition according to  claim 1 , wherein the one or more monoglycerides comprises glycerol monomyristoleate, glycerol monopalmitoleate, glycerol monosapienate, glycerol monooleate, glycerol monoelaidate, glycerol monovaccenate, glycerol monolinoleate, glycerol monolinoelaidate, glycerol monolinolenate, glycerol monostearidonate, glycerol monoeicosenoate, glycerol monomeadate, glycerol monoarachidonate, glycerol monoeicosapentaenoate, glycerol monoerucate, glycerol monodocosahexaenoate, or glycerol mononervonate.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 98.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16166272', '15794214', '15794197', '15794178', '15195623']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8244826468081533
- 35 USC 102 Novelty (BERT): 0.6165950080116837
- Combined Prediction Score: 0.8036938829285063
- Mean Citation Score: 530.5367660000002
- Max Citation Score: 538.4187
- Similarity Product: 517.0498792190551

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test